Advertisement

The Diabetic Charcot Foot

  • Lee C. Rogers
  • Robert G. Frykberg
Chapter
Part of the Contemporary Diabetes book series (CDI)

Abstract

The diabetic Charcot foot is a potentially limb-threatening deformity associated with peripheral neuropathy and concomitant injury. Often the precipitating injury is fairly minor, but unrecognized due to the underlying peripheral sensory neuropathy. With existing loss of protective sensation the neuropathic individual continues to walk on the injured extremity causing progressive inflammation with varying degrees of bone and joint pathology. Severe deformity can ensue that predisposes to ulceration, infection, and potential amputation. It is therefore critical to diagnose this condition early in its natural history to prevent progressive foot or ankle deformity and instability.

This chapter reviews the etiology, diagnostic methods, and various treatment options for the active and inactive Charcot arthropathy of the foot and ankle.

Keywords

Osteoarthropathy Neuropathic osteoarthropathy Charcot foot Rocker-bottom foot Diagnostic imaging Magnetic resonance imaging Exostectomy Realignment arthrodesis Bisphosphonates Calcitonin RANK-L Osteoprotegerin Inflammation Deformity 

References

  1. 1.
    Charcot JM. Sur quelaques arthropathies qui paraissent depender d’une lesion du cerveau ou de la moele epiniere. Arch Des Physiol Norm et Path. 1868;1:161–71.Google Scholar
  2. 2.
    Sanders LJ, Frykberg RG. The Charcot foot. In: Frykberg RG, editor. The high risk foot in diabetes mellitus. New York: Churchill Linvingston; 1991. p. 325–35.Google Scholar
  3. 3.
    Sanders LJ. What lessons can history teach us about the Charcot foot? Clin Podiatr Med Surg. 2008;25(1):1–15, v.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57(2):307–66.CrossRefGoogle Scholar
  5. 5.
    Bailey CC, Root HF. Neuropathic foot lesions in diabetes mellitus. N Engl J Med. 1947;236(11):397–401.CrossRefGoogle Scholar
  6. 6.
    Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetes mellitus. Medicine. 1972;51(3):191.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Frykberg RG, Kozak GP. Neuropathic arthropathy in the diabetic foot. Am Fam Physician. 1978;17(5):105–13.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Sanders LJ, Frykberg RG. Charcot neuroarthropathy of the foot. In: Bowker JH, Pfeifer MA, editors. Levin and O’Neals The diabetic foot. 6th ed. St. Louis: Mosby; 2001.Google Scholar
  9. 9.
    Cofield RH, Morrison MJ, Beabout JW. Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle. 1983;4(1):15–22.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJM. Diabetic foot syndrome evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26(5):1435–8.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Frykberg RG. Charcot foot: an update on pathogenesis and management. In: Boulton A, Connor H, Cavanagh PR, editors. The foot in diabetes. 3rd ed. Chichester: John Wiley and Sons; 2000.Google Scholar
  12. 12.
    Gazis A, Pound N, Macfarlane R, Treece K, Game F, Jeffcoate W. Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot). Diabet Med. 2004;21(11):1243–6.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Sohn M-W, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care. 2009;32(5):816–21.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    van Baal J, Hubbard R, Game F, Jeffcoate W. Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care. 2010;33(5):1086–9.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot’s arthropathy in a diabetic foot specialty clinic. J Am Podiatr Med Assoc. 1997;87(6):272–8.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Kozak GP, Campbell DR, Frykberg RG, Cavanagh PR. The diabetic Charcot foot. In: Management of diabetic foot problems. 2nd ed. Philadelphia: WB Sauners; 1995.Google Scholar
  17. 17.
    Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg. 2000;39(5 Suppl):S1–S60.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Game FL, Catlow R, Jones GR, et al. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55(1):32–5.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Del Vecchio JJ, Raimondi N, Rivarola H, Autorino C. Charcot neuroarthropathy in simultaneous kidney-pancreas transplantation: report of two cases. Diabet Foot Ankle. 2013;4.  https://doi.org/10.3402/dfa.v4i0.21819.
  20. 20.
    García Barrado F, Kuypers DR, Matricali GA. Charcot neuroarthropathy after simultaneous pancreas-kidney transplantation: risk factors, prevalence, and outcome. Clin Transplant. 2015;29(8):712–9.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Bevilacqua NJ, Bowling F, Armstrong DG. The natural history of Charcot neuroarthropathy. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 13–28.Google Scholar
  22. 22.
    Brower AC, Allman RM. Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular. Radiology. 1981;139(2):349–54.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Jeffcoate W, Lima J, Nobrega L. The Charcot foot. Diabet Med. 2000;17(4):253–8.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004;47(8):1343–53.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998;47(3):457–63.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Edelman SV, Kosofsky EM, Paul RA, Kozak GP. Neuro-osteoarthropathy (Charcot’s joint) in diabetes mellitus following revascularization surgery: three case reports and a review of the literature. Arch Intern Med. 1987;147(8):1504–8.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Gough A, Abraha H, Li F, et al. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med. 1997;14(7):527–31.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care. 1995;18(1):34–8.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Jirkovská A, Kasalický P, Boucek P, Hosová J, Skibová J. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabet Med. 2001;18(6):495–500.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45(8):1085–96.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Foltz KD, Fallat LM, Schwartz S. Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg. 2004;43(2):87–92.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Grant WP, Foreman EJ, Wilson AS, Jacobus DA, Kukla RM. Evaluation of Young’s modulus in Achilles tendons with diabetic neuroarthropathy. J Am Podiatr Med Assoc. 2005;95(3):242–6.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Grant WP, Sullivan R, Sonenshine DE, et al. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg. 1997;36(4):272–8. discussion 330PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Johnson JT. Neuropathic fractures and joint injuries Pathogenesis and rationale of prevention and treatment. J Bone Joint Surg Am. 1967;49(1):1–30.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br. 2004;86(3):378–83.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44(11):2032–7.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? Diabetologia. 2004;47(9):1488–92.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Jeffcoate WJ, Game FL. New theories on the causes of the Charcot foot in diabetes. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 29–44.Google Scholar
  39. 39.
    Petrova NL, Foster AVM, Edmonds ME. Difference in presentation of Charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care. 2004;27(5):1235–6.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Pakarinen TK, Laine HJ, Honkonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg. 2002;91(2):195–201.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Banks AS, McGlamry ED. Charcot foot. J Am Podiatr Med Assoc. 1989;79(5):213–35.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23(6):796–800.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    McGill M, Molyneaux L, Bolton T, Ioannou K, Uren R, Yue DK. Response of Charcot’s arthropathy to contact casting: assessment by quantitative techniques. Diabetologia. 2000;43(4):481–4.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. J Am Podiatr Med Assoc. 2011;101(5):437–46.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Trepman E, Nihal A, Pinzur MS. Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005;26(1):46–63.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999;38(1):34–40.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Wukich DK, Belczyk RJ. Silent neuropathic bone injuries and dislocations – stage 0. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 117–30.Google Scholar
  48. 48.
    Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med. 1989;149(10):2262–6.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Schweitzer ME, Morrison WB. MR imaging of the diabetic foot. Radiol Clin North Am. 2004;42(1):61–71.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Palestro CJ, Mehta HH, Patel M, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med. 1998;39(2):346–50.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Rogers LC, Bevilacqua NJ. Imaging of the Charcot foot. Clin Podiatr Med Surg. 2008;25(2):263–274, vii.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;35(4):280–3.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Eichenholtz SN. Charcot joints. Springfield, IL: Charles C. Thomas; 1966.Google Scholar
  54. 54.
    Frykberg RG, Mendeszoon ER. Charcot arthropathy: pathogenesis and management. Wounds. 2000;12(6; SUPP/B):35B–42B.Google Scholar
  55. 55.
    Newman JH. Spontaneous dislocation in diabetic neuropathy. A report of six cases. J Bone Joint Surg Br. 1979;61-B(4):484–8.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Lesko P, Maurer RC. Talonavicular dislocations and midfoot arthropathy in neuropathic diabetic feet. Natural course and principles of treatment. Clin Orthop Relat Res. 1989;240:226–31.Google Scholar
  57. 57.
    Harris JR, Brand PW. Patterns of disintegration of the tarsus in the anaesthetic foot. J Bone Joint Surg Br. 1966;48(1):4–16.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Kathol MH, El-Khoury GY, Moore TE, Marsh JL. Calcaneal insufficiency avulsion fractures in patients with diabetes mellitus. Radiology. 1991;180(3):725–9.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    El-Khoury GY, Kathol MH. Neuropathic fractures in patients with diabetes mellitus. Radiology. 1980;134(2):313–6.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Sella EJ, Grosser DM. Imaging modalities of the diabetic foot. Clin Podiatr Med Surg. 2003;20(4):729–40.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Seabold JE, Flickinger FW, Kao SC, et al. Indium-111-leukocyte/technetium-99m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med. 1990;31(5):549–56.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Schauwecker DS, Park HM, Burt RW, Mock BH, Wellman HN. Combined bone scintigraphy and indium-111 leukocyte scans in neuropathic foot disease. J Nucl Med. 1988;29(10):1651–5.PubMedPubMedCentralGoogle Scholar
  63. 63.
    Johnson JE, Kennedy EJ, Shereff MJ, Patel NC, Collier BD. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int. 1996;17(1):10–6.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Blume PA, Dey HM, Daley LJ, Arrighi JA, Soufer R, Gorecki GA. Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes. J Foot Ankle Surg. 1997;36(2):120–6. discussion 160PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Croll SD, Nicholas GG, Osborne MA, Wasser TE, Jones S. Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. J Vasc Surg. 1996;24(2):266–70.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Morrison WB, Schweitzer ME, Batte WG, Radack DP, Russel KM. Osteomyelitis of the foot: relative importance of primary and secondary MR imaging signs. Radiology. 1998;207(3):625–32.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Höpfner S, Krolak C, Kessler S, et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int. 2004;25(12):890–5.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Schon LC, Marks RM. The management of neuroarthropathic fracture-dislocations in the diabetic patient. Orthop Clin North Am. 1995;26(2):375–92.PubMedPubMedCentralGoogle Scholar
  69. 69.
    Yu GV, Hudson JR. Evaluation and treatment of stage 0 Charcot’s neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc. 2002;92(4):210–20.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Brodsky JW, Rouse AM. Exostectomy for symptomatic bony prominences in diabetic Charcot feet. Clin Orthop Relat Res. 1993;296:21–6.Google Scholar
  71. 71.
    Schon LC, Weinfeld SB, Horton GA, Resch S. Radiographic and clinical classification of acquired midtarsus deformities. Foot Ankle Int. 1998;19(6):394–404.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Frykberg RG, Rogers LC. Classification of the Charcot foot. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 55–64.Google Scholar
  73. 73.
    Rogers LC, Bevilacqua NJ. The diagnosis of Charcot foot. Clin Podiatr Med Surg. 2008;25(1):43–51, vi.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Viswanathan V, Kesavan R, Kavitha KV, Kumpatla S. Evaluation of Rogers Charcot foot classification system in south Indian diabetic subjects with Charcot foot. J Diabet Foot Complication. 2010;4(3):67–70.Google Scholar
  75. 75.
    Snyder RJ, Frykberg RG, Rogers LC, et al. The management of diabetic foot ulcers through optimal off-loading: building consensus guidelines and practical recommendations to improve outcomes. J Am Podiatr Med Assoc. 2014;104(6):555–67.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Pinzur M. Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int. 2004;25(8):545–9.PubMedCrossRefGoogle Scholar
  77. 77.
    Morgan JM, Biehl WC 3rd, Wagner FW Jr. Management of neuropathic arthropathy with the Charcot restraint orthotic Walker. Clin Orthop Relat Res. 1993;296:58–63.Google Scholar
  78. 78.
    Armstrong DG, Short B, Espensen EH, Abu-Rumman PL, Nixon BP, Boulton AJM. Technique for fabrication of an “Instant Total-Contact Cast” for treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc. 2002;92(7):405–8.PubMedCrossRefGoogle Scholar
  79. 79.
    Caputo GM, Ulbrecht J, Cavanagh PR, Juliano P. The Charcot foot in diabetes: six key points. Am Fam Physician. 1998;57(11):2705–10.PubMedPubMedCentralGoogle Scholar
  80. 80.
    Saltzman CL, Johnson KA, Goldstein RH, Donnelly RE. The patellar tendon-bearing brace as treatment for neurotrophic arthropathy: a dynamic force monitoring study. Foot Ankle. 1992;13(1):14–21.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg. 2004;43(5):285–9.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med. 1994;11(1):28–31.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Pitocco D, Ruotolo V, Caputo S, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy a randomized controlled trial. Diabetes Care. 2005;28(5):1214–5.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Bem R, Jirkovská A, Fejfarová V, Skibová J, Jude EB. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care. 2006;29(6):1392–4.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Bier RR, Estersohn HS. A new treatment for Charcot joint in the diabetic foot. J Am Podiatr Med Assoc. 1987;77(2):63–9.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Hanft JR, Goggin JP, Landsman A, Surprenant M. The role of combined magnetic field bone growth stimulation as an adjunct in the treatment of neuroarthropathy/Charcot joint: an expanded pilot study. J Foot Ankle Surg. 1998;37(6):510–5. discussion 550–551PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Grady JF, O’Connor KJ, Axe TM, Zager EJ, Dennis LM, Brenner LA. Use of electrostimulation in the treatment of diabetic neuroarthropathy. J Am Podiatr Med Assoc. 2000;90(6):287–94.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Strauss E, Gonya G. Adjunct low intensity ultrasound in Charcot neuroarthropathy. Clin Orthop Relat Res. 1998;349:132–8.CrossRefGoogle Scholar
  89. 89.
    Hockenbury RT, Gruttadauria M, McKinney I. Use of implantable bone growth stimulation in Charcot ankle arthrodesis. Foot Ankle Int. 2007;28(9):971–6.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Lowery NJ, Woods JB, Armstrong DG, Wukich DK. Surgical management of Charcot neuroarthropathy of the foot and ankle: a systematic review. Foot Ankle Int. 2012;33(2):113–21.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Steindler A. The tabetic arthropathies. JAMA. 1931;96(4):250–6.CrossRefGoogle Scholar
  92. 92.
    Samilson RL, Sankaran B, Bersani FA, Smith AD. Orthopedic management of neuropathic joints. AMA Arch Surg. 1959;78(1):115–21.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Heiple KG, Cammarn MR. Diabetic neuroarthropathy with spontaneous peritalar fracture-dislocation. JBJS Case Connector. 1966;48(6):1177–81.Google Scholar
  94. 94.
    Baravarian B, Van Gils CC. Arthrodesis of the Charcot foot and ankle. Clin Podiatr Med Surg. 2004;21(2):271–89.PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    Leventen EO. Charcot foot—a technique for treatment of chronic plantar ulcer by saucerization and primary closure. Foot Ankle. 1986;6(6):295–9.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Catanzariti AR, Mendicino R, Haverstock B. Ostectomy for diabetic neuroarthropathy involving the midfoot. J Foot Ankle Surg. 2000;39(5):291–300.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Newman JH. Non-infective disease of the diabetic foot. J Bone Joint Surg Br. 1981;63B(4):593–6.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Pinzur MS. Benchmark analysis of diabetic patients with neuropathic (Charcot) foot deformity. Foot Ankle Int. 1999;20(9):564–7.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Myerson MS, Alvarez RG, Lam PW. Tibiocalcaneal arthrodesis for the management of severe ankle and hindfoot deformities. Foot Ankle Int. 2000;21(8):643–50.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Pinzur MS. Surgical management – history and general principles. In: Frykberg RG, editor. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 165–88.Google Scholar
  101. 101.
    Rosenblum BI, Giurini JM, Miller LB, Chrzan JS, Habershaw GM. Neuropathic ulcerations plantar to the lateral column in patients with Charcot foot deformity: a flexible approach to limb salvage. J Foot Ankle Surg. 1997;36(5):360–3.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL. Arthrodesis as an early alternative to nonoperative management of Charcot arthropathy of the diabetic foot. J Bone Joint Surg Am. 2000;82-A(7):939–50.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Wang JC, Le AW, Tsukuda RK. A new technique for Charcot’s foot reconstruction. J Am Podiatr Med Assoc. 2002;92(8):429–36.PubMedCrossRefPubMedCentralGoogle Scholar
  104. 104.
    Jolly GP, Zgonis T, Polyzois V. External fixation in the management of Charcot neuroarthropathy. Clin Podiatr Med Surg. 2003;20(4):741–56.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Pinzur MS, Sammarco VJ, Wukich DK. Charcot foot: a surgical algorithm. Instr Course Lect. 2012;61:423–38.PubMedPubMedCentralGoogle Scholar
  106. 106.
    Farber DC, Juliano PJ, Cavanagh PR, Ulbrecht J, Caputo G. Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int. 2002;23(2):130–4.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Thompson RC Jr, Clohisy DR. Deformity following fracture in diabetic neuropathic osteoarthropathy. Operative management of adults who have type-I diabetes. J Bone Joint Surg Am. 1993;75(12):1765–73.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Marks RM, Parks BG, Schon LC. Midfoot fusion technique for neuroarthropathic feet: biomechanical analysis and rationale. Foot Ankle Int. 1998;19(8):507–10.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Bevilacqua NJ, Rogers LC. Surgical management of Charcot midfoot deformities. Clin Podiatr Med Surg. 2008;25(1):81–94, vii.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    Cooper PS. Application of external fixators for management of Charcot deformities of the foot and ankle. Semin Vasc Surg. 2003;16(1):67–78.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Lamm BM, Paley D. Reduction of neuropathic foot deformity with gradual external fixation distraction and midfoot fusion. In: Frykberg RG, editor. The Diabetic Charcot Foot: Principles and Management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 197–210.Google Scholar
  112. 112.
    Wukich DK, Zgonis T. Circular external fixation in Charcot neuroarthropathy. In: Frykberg RG, editor. The diabetic charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010. p. 233–44.Google Scholar
  113. 113.
    Mendicino RW, Catanzariti AR, Saltrick KR, et al. Tibiotalocalcaneal arthrodesis with retrograde intramedullary nailing. J Foot Ankle Surg. 2004;43(2):82–6.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Pinzur MS, Kelikian A. Charcot ankle fusion with a retrograde locked intramedullary nail. Foot Ankle Int. 1997;18(11):699–704.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Moore TJ, Prince R, Pochatko D, Smith JW, Fleming S. Retrograde intramedullary nailing for ankle arthrodesis. Foot Ankle Int. 1995;16(7):433–6.PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Najafi B, Crews RT, Armstrong DG, Rogers LC, Aminian K, Wrobel J. Can we predict outcome of surgical reconstruction of Charcot neuroarthropathy by dynamic plantar pressure assessment?—a proof of concept study. Gait Posture. 2010;31(1):87–92.PubMedCrossRefPubMedCentralGoogle Scholar
  117. 117.
    Bevilacqua NJ, Dankert JP, Rogers LC, Armstrong DG. A technique to protect external fixation devices. J Foot Ankle Surg. 2008;47(2):172–4.PubMedCrossRefPubMedCentralGoogle Scholar
  118. 118.
    Rogers LC, Bevilacqua NJ, Frykberg RG, Armstrong DG. Predictors of postoperative complications of Ilizarov external ring fixators in the foot and ankle. J Foot Ankle Surg. 2007;46(5):372–5.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Wukich DK, Belczyk RJ, Burns PR, Frykberg RG. Complications encountered with circular ring fixation in persons with diabetes mellitus. Foot Ankle Int. 2008;29(10):994–1000.PubMedCrossRefPubMedCentralGoogle Scholar
  120. 120.
    Clohisy DR, Thompson RC Jr. Fractures associated with neuropathic arthropathy in adults who have juvenile-onset diabetes. J Bone Joint Surg Am. 1988;70(8):1192–200.PubMedCrossRefPubMedCentralGoogle Scholar
  121. 121.
    Eckardt A, Schöllner C, Decking J, et al. The impact of Syme amputation in surgical treatment of patients with diabetic foot syndrome and Charcot-neuro-osteoarthropathy. Arch Orthop Trauma Surg. 2004;124(3):145–50.PubMedCrossRefPubMedCentralGoogle Scholar
  122. 122.
    Tan AL, Greenstein A, Jarrett SJ, McGonagle D. Acute neuropathic joint disease: a medical emergency? Diabetes Care. 2005;28(12):2962–4.PubMedCrossRefPubMedCentralGoogle Scholar
  123. 123.
    Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med. 2005;22(12):1707–12.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Lee C. Rogers
    • 1
  • Robert G. Frykberg
    • 2
  1. 1.Amputation Prevention Centers of AmericaWhite PlainsUSA
  2. 2.Podiatry SectionPhoenix VA Healthcare SystemPhoenixUSA

Personalised recommendations